A previous study using samples from the VAX004 trial, which assessed a gp120 protein vaccine, demonstrated that prior vaccination had only a minor effect on neutralizing antibody responses following HIV-1 infection (2, 23). This evidence concerns the gene ITIH4 and HIV-1 infection.